IDSA: Intranasal Live-Attenuated COVID-19 Vaccine Induces Response

TUESDAY, Oct. 17, 2023 -- Two doses of a novel intranasal live-attenuated COVID-19 vaccine, CoviLiv, induce poly-antigenic immune response, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek),...